Featured Research

from universities, journals, and other organizations

Penn Scientists Develop Novel Procedure To Make Cancer Vaccines

Date:
October 10, 1997
Source:
University of Pennsylvania Medical Center
Summary:
University of Pennsylvania Medical Center researchers have devised a unique and rapid way to transform plentiful monocytes into battle-ready dendritic cells to make a new kind of cancer vaccine. In test-tube cultures, the modified cells have already shown their ability to activate T cells within one week.

Researchers at the University of Pennsylvania Medical Center have devised aunique and rapid way to transform plentiful monocytes into battle-readydendritic cells in an effort to boost the immune system's cancer-fightingforces. In test-tube cultures, the modified cells have already shown theirability to activate T cells within one week.

Penn investigators collaborated with a team from the National CancerInstitute in this ongoing research. The next step, the scientists say, will beto demonstrate that the dendritic cells can induce a clinically useful and saferesponse in the bodies of cancer patients.

"Our procedure could be used to produce vaccines against cancers,including breast, colon, and melanoma," says Brian J. Czerniecki, MD, PhD,assistant professor of surgery in Penn's School of Medicine. Although vaccinesare typically thought of as a preventative treatment--administered to patientsbefore contracting a disease--most cancer vaccines are designed to spur theimmune system into attacking existing tumors. Czerniecki and colleagues reporttheir findings in the October 15 issue of the Journal of Immunology.

Dendritic cells play a leading role in generating an immune response.After ingesting antigens (molecular tags, of sorts, found on all substances),dendritic cells attach pieces of internalized antigens to their outer surfacesto attract the attention of T cells. The dendritic cells and their antigen flagstravel to the lymph nodes--where T cells reside--and display the antigens toactivate T cells. The T cells then trigger a complicated immune response toeliminate the antigens, including those on tumor cells.

Until recently cancer vaccines have used additives called adjuvants tomobilize dendritic cells. Now, scientists have found ways to generate dendriticcells directly.

This concept is working in animal models, but the problem in humans,says Czerniecki, is that there hasn't been an easy way to produce enoughdendritic cells, which make up only 1 percent of the peripheral blood. Tocompensate for such a minuscule pool, Czerniecki's team looked to monocytes astheir starting cell type because they account for 10 percent of human blood.

This hypothesis--described by Cerzniecki and his NCI collaborator PeterCohen--proved golden because the researchers' method not only yielded dendriticcells from monocytes, but created them in surprisingly large quantities, andwith amazing speed and potency. "With this technique we can supply very largenumbers of activated dendritic cells, all directed at cancer antigens," saysCzerniecki.

The scientists separate the monocytes from a donor's blood and treatthem with calcium, and now, in an as-yet unpublished step, they also addinflammatory molecules called cytokines to further activate the dendritic cells.The surface of these modified cells are tagged with a melanoma antigen. Theflagged dendritic cells are then grown with the donor's T cells, and after oneweek, even T cells from donors without melanoma can fight melanoma tumors.

Using the modified dendritic cells, the team of Czerniecki and Cohenplans to conduct a human clinical trial with melanoma patients next spring. "Weplan to kick start the immune system of these patients by giving themmelanoma-antigen-labeled dendritic cells," he explains. "These cells will havethe instructions to activate T cells to find the melanoma tumor and work atshrinking it." Using a similar, but weaker vaccine, German colleagues ofCzerniecki's have detected shrinkage and disappearance of melanoma tumors in ahandful of patients.

National Institutes of Health researchers Charles Carter and Steven A.Rosenberg also collaborated on the study, which was supported by the AmericanCancer Society, and the Arthur Pardee, Thomas B. McCabe, and HarringtonFoundations.


Story Source:

The above story is based on materials provided by University of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Pennsylvania Medical Center. "Penn Scientists Develop Novel Procedure To Make Cancer Vaccines." ScienceDaily. ScienceDaily, 10 October 1997. <www.sciencedaily.com/releases/1997/10/971010064009.htm>.
University of Pennsylvania Medical Center. (1997, October 10). Penn Scientists Develop Novel Procedure To Make Cancer Vaccines. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1997/10/971010064009.htm
University of Pennsylvania Medical Center. "Penn Scientists Develop Novel Procedure To Make Cancer Vaccines." ScienceDaily. www.sciencedaily.com/releases/1997/10/971010064009.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins